D
DRSLINQ is developing a mobile EKG device platform that accurately evaluates chest pain patients to determine the need for emergency room intervention. This technology improves patient triage efficiency, potentially decreasing wait times and enhancing outcomes for those with cardiac symptoms.
Updated 20 months ago
Funding
$50K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
X
Funding rounds are not available yet.
Founders
Product
Features
- DRSLINQ is developing a mobile EKG device platform that accurately evaluates chest pain patients to determine the need for emergency room intervention. This technology improves patient triage efficiency, potentially decreasing wait times and enhancing outcomes for those with cardiac symptoms.